{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:21:39Z","timestamp":1788312099838,"version":"build-2803163510"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Elimination of tuberculosis (TB) disease in the US hinges on the ability of tests to detect individual risk of developing disease to inform prevention. The relative performance of 3 available TB tests\u2014the tuberculin skin test (TST) and 2 interferon-\u03b3 release assays (IGRAs; QuantiFERON-TB Gold In-Tube [QFT-GIT] and SPOT.TB [TSPOT])\u2014in predicting TB disease development in the US remains unknown.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare the performance of the TST with the QFT-GIT and TSPOT IGRAs in predicting TB disease in high-risk populations.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This prospective diagnostic study included participants at high risk of TB infection (TBI) or progression to TB disease at 10 US sites between 2012 and 2020. Participants of any age who had close contact with a case patient with infectious TB, were born in a country with medium or high TB incidence, had traveled recently to a high-incidence country, were living with HIV infection, or were from a population with a high local prevalence were enrolled from July 12, 2012, through May 5, 2017. Participants were assessed for 2 years after enrollment and through registry matches until the study end date (November 15, 2020). Data analysis was performed in June 2023.<\/jats:p><\/jats:sec>Exposures<\/jats:title>At enrollment, participants were concurrently tested with 2 IGRAs (QFT-GIT from Qiagen and TSPOT from Oxford Immunotec) and the TST. Participants were classified as case patients with incident TB disease when diagnosed more than 30 days from enrollment.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Estimated positive predictive value (PPV) ratios from generalized estimating equation models were used to compare test performance in predicting incident TB. Incremental changes in PPV were estimated to determine whether predictive performance significantly improved with the addition of a second test. Case patients with prevalent TB were examined in sensitivity analysis.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 22\u202f020 eligible participants were included in this study. Their median age was 32 (range, 0-102) years, more than half (51.2%) were male, and the median follow-up was 6.4 (range, 0.2-8.3) years. Most participants (82.0%) were born outside the US, and 9.6% were close contacts. Tuberculosis disease was identified in 129 case patients (0.6%): 42 (0.2%) had incident TB and 87 (0.4%) had prevalent TB. The TSPOT and QFT-GIT assays performed significantly better than the TST (PPV ratio, 1.65 [95% CI, 1.35-2.02] and 1.47 [95% CI, 1.22-1.77], respectively). The incremental gain in PPV, given a positive TST result, was statistically significant for positive QFT-GIT and TSPOT results (1.64 [95% CI, 1.40-1.93] and 1.94 [95% CI, 1.65-2.27], respectively).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this diagnostic study assessing predictive value, IGRAs demonstrated superior performance for predicting incident TB compared with the TST. Interferon-\u03b3 release assays provided a statistically significant incremental improvement in PPV when a positive TST result was known. These findings suggest that IGRA performance may enhance decisions to treat TBI and prevent TB.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.4769","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:17:42Z","timestamp":1712157462000},"page":"e244769","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of Tuberculin Skin Testing and Interferon-\u03b3 Release Assays in Predicting Tuberculosis Disease"],"prefix":"10.1001","volume":"7","author":[{"given":"Tracy","family":"Ayers","sequence":"first","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Raykin","sequence":"additional","affiliation":[{"name":"Peraton, Reston, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Peraton, Reston, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Belknap","sequence":"additional","affiliation":[{"name":"Public Health Institute at Denver Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Brostrom","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Tuberculosis Control Program, Hawai\u2019i Department of Health, Honolulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Khurana","sequence":"additional","affiliation":[{"name":"Maricopa County Department of Public Health, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lauzardo","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Health Behavior and Health Systems, University of North Texas Health Science Center, Fort Worth"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Narita","sequence":"additional","affiliation":[{"name":"Public Health\u2014Seattle and King County, Seattle, Washington"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April C.","family":"Pettit","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pyan","sequence":"additional","affiliation":[{"name":"Maryland Department of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya L.","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araxi","family":"Polony","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Flood","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CDC Tuberculosis Epidemiologic Studies Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pascopella","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Ahmed","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylynn","family":"Aiona","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Lovato","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Reves","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leti","family":"Trujillo","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Garfein","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Farrow","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Stout","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Zavala","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Blumberg","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tapia","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alawode","family":"Oladele","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Largen","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Dorman","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Maltas","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Munk","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maunank","family":"Shah","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurimar","family":"Ayala","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cronin","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saleeb","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Haas","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoseph","family":"Sorri","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kozik","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Moore","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Keh","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Romo","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C","family":"Li","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Reynolds-Bigby","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Nancy","family":"Seraphin","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Board","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gallups","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Stockbridge","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horne","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Atchley","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Maruri","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Sterling","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kerrigan","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Wright","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kursten","family":"Lyon","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Turner","sequence":"additional","affiliation":[{"name":"for the CDC Tuberculosis Epidemiologic Studies Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"issue":"4","key":"zoi240203r1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries.","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"issue":"11","key":"zoi240203r2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011-2012.","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"issue":"17","key":"zoi240203r3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.2023.3954","article-title":"Screening for latent tuberculosis infection in adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"329","author":"Jonas","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"zoi240203r4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13690-023-01098-z","article-title":"Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials.","volume":"81","author":"Assefa","year":"2023","journal-title":"Arch Public Health"},{"issue":"1","key":"zoi240203r5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"key":"zoi240203r7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/immunol.2013.31.issue-1","article-title":"The immune response in tuberculosis.","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"zoi240203r8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-? release assay for developing active tuberculosis: an update.","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"zoi240203r9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-? release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"issue":"9","key":"zoi240203r10","first-page":"1209","article-title":"Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.","volume":"14","author":"Harstad","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"zoi240203r11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"zoi240203r12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"issue":"6","key":"zoi240203r13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1164\/rccm.200912-1875OC","article-title":"T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease.","volume":"182","author":"Leung","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"zoi240203r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold\u00ae in predicting tuberculosis disease in an adolescent cohort study in South Africa.","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"zoi240203r15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-? release assays for incident active tuberculosis: a systematic review and meta-analysis.","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"zoi240203r16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12889-016-3519-6","article-title":"Tuberculosis progression rates in U.S. immigrants following screening with interferon-gamma release assays.","volume":"16","author":"Blount","year":"2016","journal-title":"BMC Public Health"},{"issue":"10","key":"zoi240203r17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-? release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"zoi240203r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002814","article-title":"Predicting progression to active tuberculosis: a rate-limiting step on the path to elimination.","volume":"16","author":"Lalvani","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"zoi240203r19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children.","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"10","key":"zoi240203r20","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/cid\/ciac248","article-title":"Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.","volume":"75","author":"Holzman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi240203r21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.300.4.405","article-title":"Tuberculosis among foreign-born persons in the United States.","volume":"300","author":"Cain","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"zoi240203r22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(21)00145-6","article-title":"Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.","volume":"22","author":"Ho","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"zoi240203r23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-? release assays in children <15 years of age.","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"zoi240203r26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion.","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"issue":"2","key":"zoi240203r30","first-page":"193","article-title":"Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts.","volume":"41","author":"Ozt\u00fcrk","year":"2007","journal-title":"Mikrobiyol Bul"},{"issue":"5","key":"zoi240203r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097366","article-title":"Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.","volume":"9","author":"O\u2019Shea","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"zoi240203r32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"zoi240203r33","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model.","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"20","key":"zoi240203r34","doi-asserted-by":"publisher","first-page":"13529","DOI":"10.3390\/ijerph192013529","article-title":"Economic evaluation of screening strategy for latent tuberculosis infection (LTBI) in contacts of tuberculosis patients: systematic review and quality assessment.","volume":"19","author":"Yoopetch","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"zoi240203r35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"7","key":"zoi240203r36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/thoraxjnl-2017-211147","article-title":"Stratification by interferon-? release assay level predicts risk of incident TB.","volume":"73","author":"Winje","year":"2018","journal-title":"Thorax"},{"issue":"5","key":"zoi240203r37","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","article-title":"Comparing the diagnostic performance of QuantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis.","volume":"73","author":"Oh","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"zoi240203r38","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00985-19","article-title":"Comparing QuantiFERON-TB Gold Plus with other tests to diagnose Mycobacterium tuberculosis infection.","volume":"57","author":"Venkatappa","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"12","key":"zoi240203r39","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.21037\/jtd","article-title":"Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects.","volume":"11","author":"Hong","year":"2019","journal-title":"J Thorac Dis"},{"key":"zoi240203r6","volume-title":"Implementing the End TB Strategy: The Essentials","author":"World Health Organization","year":"2015"},{"key":"zoi240203r27","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction","author":"Pepe","year":"2004"},{"key":"zoi240203r24","unstructured":"Centers for Disease Control and Prevention. Fact sheet: targeted TB testing & interpreting skin test results. 2011. Accessed June 10, 2023. https:\/\/www.cdc.gov\/tb\/publications\/factsheets\/testing\/skintestresults.htm"},{"key":"zoi240203r25","unstructured":"Centers for Disease Control and Prevention. 2020 Report of verified case of tuberculosis (RVCT) instruction manual. Appendix A. 2021. Accessed June 10, 2023. https:\/\/www.cdc.gov\/tb\/programs\/rvct\/default.htm"},{"key":"zoi240203r28","unstructured":"Therneau? T. Survival: a package for survival analysis in R. R package version 3.4-0. 2022. https:\/\/cran.r-project.org\/web\/packages\/survival\/index.html"},{"key":"zoi240203r29","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2023. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2817001\/ayers_2024_oi_240203_1715703203.35437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T15:00:27Z","timestamp":1716217227000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2817001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4769","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]}}}